This announcement is a separate document:
雲頂新耀-B：自願公告 與KEZAR訂立合作及授權許可協議於大中華區及其他亞洲市場開發及商業化ZETOMIPZOMIB
EVEREST MED-B: VOLUNTARY ANNOUNCEMENT COLLABORATION AND LICENSE AGREEMENT WITH KEZAR TO DEVELOP AND COMMERCIALIZE ZETOMIPZOMIB IN GREATER CHINA AND OTHER ASIAN MARKETS
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.